Condition
    Preliminary
    Effectiveness 2/5

    Omega-3 Fatty Acids for Post-Concussion Syndrome

    Mechanistically plausible for concussion recovery, with human evidence still too thin to recommend confidently.

    Overview

    Mechanistically plausible for concussion recovery, with human evidence still too thin to recommend confidently.

    Verdict

    Insufficient evidence

    Strong animal data for axonal protection after brain injury, but human trials are small and have not yet shown symptom benefit.

    How It Works

    DHA is the dominant structural fatty acid in neuronal membranes. After diffuse axonal injury, DHA supports membrane repair, reduces axonal swelling markers, and dampens neuroinflammation through resolvin and neuroprotectin D1 pathways, which in animal models reduces markers of axonal injury after controlled impact.

    Dosing & Protocol

    Typical dose

    Recommended dose
    2-3 g daily of combined EPA and DHA with DHA predominant, taken with food
    Expected timeframe
    Any effect would be over weeks; there is no established timeframe from clinical data

    Protocol

    form
    Not applicable
    duration
    Not applicable
    co factor
    Evidence is insufficient: no adequately powered randomised trial has tested omega-3 in post-concussion syndrome. Doses of 1-3 g/day combined EPA+DHA have been proposed from animal neuroprotection data and small case series, with no controlled symptom outcomes. Graded return to activity, vestibular and oculomotor rehabilitation, sleep restoration and headache management are the interventions with evidence.
    titration
    Not applicable
    starting dose
    Not applicable as an established treatment

    Evidence

    What the studies say

    Preclinical evidence is unusually consistent: rodent studies show reduced beta-amyloid precursor protein accumulation and improved cognitive outcomes with DHA supplementation before and after injury. Human evidence has not caught up. A randomised trial in American football players found DHA at 2-6 g daily attenuated rises in serum neurofilament light, a blood marker of axonal injury, across a season, but this is a biomarker rather than a clinical outcome. Case reports in severe injury are widely cited and are not evidence. No adequately powered trial has shown faster symptom resolution or reduced rates of persistent post-concussion symptoms. The safety profile is good and the rationale is sound, so it is a reasonable adjunct to the interventions that do have evidence — graded sub-threshold exercise, sleep, and vestibular therapy — rather than a substitute for them.

    Nutritional Supplement and Dietary Interventions as a Prophylaxis or Treatment of Sub-Concussive Repetitive Head Impact and Mild Traumatic Brain Injury: A Systematic Review

    Score: 6/10
    2023
    systematic_review
    n=1139

    Feinberg C

    Strongest evidence supports n-3FA utility for neurotrauma prevention in athletes exposed to SRHI.

    View source

    Safety

    Caveats

    Bleeding risk is a consideration in the acute phase after head trauma where intracranial haemorrhage has not been excluded. Do not start high-dose omega-3 before imaging clearance in significant head injury.

    Less likely to help if

    People whose persistent symptoms are driven by cervical injury, vestibular dysfunction, medication overuse headache or anxiety will not benefit from a membrane-repair mechanism.

    Medical Disclaimer

    The information provided on this website is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any supplement regimen.

    Individual results may vary. The statements on this website have not been evaluated by the Food and Drug Administration. Products and information are not intended to diagnose, treat, cure, or prevent any disease.